Evidence for Altered White Matter Organisation After Mild Traumatic Brain Injury: A Scoping Review on the Use of Diffusion MRI and Blood-Based Biomarkers to Investigate Acute Pathology and Relationship to Persistent Post-Concussion Symptoms.

AXONAL INJURY BIOMARKERS Diffusion Tensor Imaging TRAUMATIC BRAIN INJURY

Journal

Journal of neurotrauma
ISSN: 1557-9042
Titre abrégé: J Neurotrauma
Pays: United States
ID NLM: 8811626

Informations de publication

Date de publication:
03 Aug 2024
Historique:
medline: 3 8 2024
pubmed: 3 8 2024
entrez: 3 8 2024
Statut: aheadofprint

Résumé

Mild traumatic brain injury (mTBI) is the most common form of traumatic brain injury. Post-concussive symptoms typically resolve after a few weeks although up to 20% of people experience these symptoms for >3 months, termed persistent-post concussive symptoms (PPCS). Subtle white matter (WM) microstructural damage is thought to underlie neurological and cognitive deficits experienced post-mTBI. Evidence suggests that diffusion magnetic resonance imaging (dMRI) and blood-based biomarkers could be used as surrogate markers of WM organisation. We conducted a scoping review according to PRISMA-ScR guidelines, aiming to collate evidence for the use of dMRI and/or blood-based biomarkers of WM organisation, in mTBI and PPCS, and document relationships between WM biomarkers and symptoms. We focused specifically on biomarkers of axonal or myelin integrity post-mTBI. Biomarkers excluded from this review therefore included: astroglial, perivascular, endothelial and inflammatory markers. A literature search performed across four databases: EMBASE, Scopus, Google Scholar and ProQuest identified 100 records: 68 analysed dMRI, 28 assessed blood-based biomarkers and 4 used both. Blood biomarker studies commonly assessed axonal cytoskeleton proteins (i.e. tau); dMRI studies assessed measures of WM organisation (i.e. fractional anisotropy). Significant biomarker alterations were frequently associated with heightened symptom burden and prolonged recovery time post-injury. These data suggests that dMRI and blood-based biomarkers may be useful proxies of WM organisation, though few studies assessed these complementary measures in parallel and the relationship between modalities remains unclear. Further studies are warranted to assess the benefit of a combined biomarker approach in evaluating alterations to WM organisation after mTBI.

Identifiants

pubmed: 39096132
doi: 10.1089/neu.2024.0039
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Melissa Papini (M)

Curtin University, Curtin Medical School, Ralph and Patricia Sarich Neuroscience Research Institute, 8 Verdun Street, Nedlands, Perth, Western Australia, Australia, 6009; melissa.papini@curtin.edu.au.

André Avila (A)

Curtin University, Curtin Medical School, Perth, Western Australia, Australia; andre.avila@curtin.edu.au.

Melinda Fitzgerald (M)

Curtin University, Curtin Health Innovation Research Institute, Building RR, QEII Medical Centre, 8 Verdun St, Nedlands, Western Australia, Australia, 6009; lindy.fitzgerald@curtin.edu.au.

Sarah Claire Hellewell (SC)

Curtin University, Faculty of Health Sciences, 8 Verdun Street, Nedlands, Western Australia, Australia, 6009.
Curtin Health Innovation Research Institute Biosciences, Bentley, Western Australia, Australia, 6845; sarah.hellewell@curtin.edu.au.

Classifications MeSH